-height: 30px"> My research team solved the mystery of the formation of methylmercury, the culprit of "Minamata disease" in the environment
The Ministry of Finance sets up a PPP leading group to solve the multi-head management dilemma
Time of Update: 2021-05-02
, Vice Minister of Finance Wang Baoan presided over the first meeting of the PPP Work Leading Group to study the PPP management organization establishment plan, discuss and improve the PPP work guidance notice, and clarify the division of responsibilities
Huatong Refrigeration Supplements Urgent Manufacturers Started Emergency Plan to Solve Transportation Problems
Time of Update: 2021-04-30
: 14pxfont-family:">Huatong cold supply manufacturer launched an emergency supply plan, and the three production bases opened up domestically. Transportation channels
Industry | Central Asia began to solve coating safety issues
Time of Update: 2021-04-30
>A local paint industry person who asked not to be named said that technically, the region has become one of the world's markets, and price is the only important factor. As for non-food products, no one cares about safety
The Beijing-Tianjin-Hebei air pollution has finally "solved the case"!
Time of Update: 2021-04-29
What do you think of the value of solving this case?Chai Fahe: This time we propose that emissions exceeding 50% of the environmental capacity are the root cause of heavy pollution, and it is measured by scientific methods.
Freshly released | 2021 SGO LBA heavy research solves the mystery!
Time of Update: 2021-04-28
The Phase Ib KEYNOTE-028 study showed that pembrolizumab showed certain anti-tumor activity in PD-L1-positive vulvar cancer patients with an ORR of 6%.
AstraZeneca's CLL drug Calquence is approved by NICE in the UK
Time of Update: 2021-04-28
CompilationFan DongdongA few days ago, the National Institute of Health and Clinical Optimization (NICE) decided to recommend AstraZeneca’s BTK inhibitor Calquence (Acalabrutinib) into the British National Health Service (NHS) for the treatment of certain adult chronic lymphocytic leukemia (CLL).
It is not realistic to expect the last mile problem of innovative drugs to be solved immediately
Time of Update: 2021-04-27
An industry researcher pointed out to the eight-point health news that there are policy advantages for the drugs in the medical insurance catalog to enter the hospital.
Express | Aiming to solve the problem of side effects of IL-2 immunotherapy, Xinrui completes US$55 million in Series A financing
Time of Update: 2021-04-27
specific immune cell types to obtain the desired immune response while reducing the side effects of the therapy. The company's main product candidate, AB248, is a fusion protein that selectively activates the IL-2
AstraZeneca/Mersk’s Lynparza combined with Roche Avastin is recommended in the UK for the treatment of ovarian cancer
Time of Update: 2021-04-27
The US FDA approved the drug for use in advanced ovarian cancer with germline BRCA mutation (gBRCAm) that has received three or more chemotherapies.
How does the first-line golden combination of gastric cancer solve the Chinese problem?
Time of Update: 2021-04-24
immunotherapy have clinical value in the first-line treatment of advanced or metastatic gastric cancer? This unresolved question was finally confirmed by CheckMate-649 research on the dual superiority results of OS and PFS until August last
Solve the "Achilles' Heel" of CAR-T!
Time of Update: 2021-04-23
com" target="_blank">The results showed that under the recommended phase 2 dose of lenzilumab, the objective response rate (ORR) reached 100%, and no patients had severe cytokine release syndrome (CRS) or severe neurotoxicity (NT).
The UK launches a new "human challenge test" for the new coronavirus
Time of Update: 2021-04-22
